Skip to main content
. 2023 Nov 9;11(4):163. doi: 10.3390/diseases11040163

Table 3.

Risk of bias assessment.

Trial Design Random Sequence Generation Allocation Concealment Blinding of Participants and Personnel Blinding of Outcome Assessment
Palau et al., 2022 [15] RCT + + ? +
Sharma et al., 2022 [24] RCT ? ? ? +
Jimeno-Almazán et al., 2023 [20] RCT + ? ? ?
Jimeno-Almazán et al., 2022 [21] RCT + ? ? ?
Philip et al., 2022 [23] RCT + + ? +
Mcnarry et al., 2022 [22] RCT + + ? ?